Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
Saved in:
Main Authors: | Koji Nakajima, Ayumi Korekawa, Daiki Rokunohe, Hajime Nakano, Daisuke Sawamura |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/07689a31d97d491c824f04b261b45b9e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nivolumab-Induced Exocrine Pancreatic Insufficiency
by: Boudewijn Sweep, et al.
Published: (2021) -
A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA)
by: Flavia Dei Zotti, et al.
Published: (2021) -
A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
by: Keisuke Minami, et al.
Published: (2021) -
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
by: Morten Fink, et al.
Published: (2021) -
Autoimmune hemolytic anemia in children: Clinical presentation and treatment outcome
by: Satyam Arora, et al.
Published: (2021)